Igor Aurer

Zagreb, Croatia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 71 publications

Hodgkin lymphoma: EHA Clinical Practice Guidelines for diagnosis, treatment, and follow-up.

Hodgkin lymphoma: EHA Clinical Practice Guidelines for diagnosis, treatment, and follow-up.

Journal: HemaSphere

Published: April 14, 2026

EHA-EU MCL network guidelines for diagnosis and treatment of mantle cell lymphoma.

EHA-EU MCL network guidelines for diagnosis and treatment of mantle cell lymphoma.

Journal: HemaSphere

Published: June 30, 2025

Efficacy, Toxicity and Effect of Pretreatment Cardiologic Consultation on Outcomes of Ibrutinib Therapy for Chronic Lymphocytic Leukemia-A KroHem Study.

Efficacy, Toxicity and Effect of Pretreatment Cardiologic Consultation on Outcomes of Ibrutinib Therapy for Chronic Lymphocytic Leukemia-A KroHem Study.

Journal: Cancers

Published: April 17, 2025

Bridging gaps in clinical trial accessibility and reimbursement for large B-cell lymphoma therapies across Europe.

Bridging gaps in clinical trial accessibility and reimbursement for large B-cell lymphoma therapies across Europe.

Journal: HemaSphere

Published: March 20, 2025

Large B-cell lymphoma (LBCL): EHA Clinical Practice Guidelines for diagnosis, treatment, and follow-up.

Large B-cell lymphoma (LBCL): EHA Clinical Practice Guidelines for diagnosis, treatment, and follow-up.

Journal: HemaSphere

Published: March 13, 2025

Addressing cardiovascular toxicities of Bruton tyrosine kinase inhibitors in chronic lymphocytic leukaemia: practical recommendations for haematologists in central and eastern Europe.

Addressing cardiovascular toxicities of Bruton tyrosine kinase inhibitors in chronic lymphocytic leukaemia: practical recommendations for haematologists in central and eastern Europe.

Journal: Cardio-oncology (London, England)

Published: March 05, 2025

Obinutuzumab in Combination with Alternative Chlorambucil Schedules in Front-Line Treatment of Chronic Lymphocytic Leukemia: A Study by KroHem, the Croatian Cooperative Group for Hematologic Diseases.

Obinutuzumab in Combination with Alternative Chlorambucil Schedules in Front-Line Treatment of Chronic Lymphocytic Leukemia: A Study by KroHem, the Croatian Cooperative Group for Hematologic Diseases.

Journal: Biomedicines

Published: November 26, 2024

Primary Extranodal Follicular Lymphoma: A Retrospective Survey of the International Extranodal Lymphoma Study Group (IELSG).

Primary Extranodal Follicular Lymphoma: A Retrospective Survey of the International Extranodal Lymphoma Study Group (IELSG).

Journal: Hematological oncology

Published: November 13, 2024

Autologous hematopoietic stem-cell transplantation in diffuse cutaneous systemic sclerosis: a single-center experience.

Autologous hematopoietic stem-cell transplantation in diffuse cutaneous systemic sclerosis: a single-center experience.

Journal: Reumatismo

Published: November 09, 2024

Maximum tumor diameter is associated with relapse risk in limited-stage Hodgkin lymphoma: an international study.

Maximum tumor diameter is associated with relapse risk in limited-stage Hodgkin lymphoma: an international study.

Journal: Blood advances

Published: October 21, 2024

Is COVID-19 Still a Threat? An Expert Opinion Review on the Continued Healthcare Burden in Immunocompromised Individuals.

Is COVID-19 Still a Threat? An Expert Opinion Review on the Continued Healthcare Burden in Immunocompromised Individuals.

Journal: Advances in therapy

Published: August 20, 2024

COVID-19 burden of illness in people who are immunocompromised due to cancer: an expert opinion review.

COVID-19 burden of illness in people who are immunocompromised due to cancer: an expert opinion review.

Journal: The oncologist

Published: June 18, 2024

Showing 1-12 of 71

Last Updated: 09/26/2026